ENOVIS CORP (ENOV)
US1940141062 - Common Stock
Interesting ENOV Put And Call Options For April 2025
Enovis Enters Oversold Territory (ENOV)
Enovis to Participate in Upcoming Investor Conferences
Enovis to Participate in Upcoming Investor Conferences
Wilmington, DE, May 10, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today...
ENOV Stock Earnings: Enovis Beats EPS, Beats Revenue for Q1 2024
ENOV stock results show that Enovis beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
Enovis Announces First Quarter 2024 Results
Enovis Announces First Quarter 2024 Results
Strong start to the year with sales growth of 27% on a reported basis and strong adjusted margin expansionReported first-quarter net loss from continuing...
Enovis Becomes Oversold (ENOV)
Enovis to Host First Quarter 2024 Results Conference Call on May 2nd
ENOV Makes Notable Cross Below Critical Moving Average
Notable Monday Option Activity: ENOV, JELD, MPW
Enovis to Participate in the 23rd Annual Needham Virtual Healthcare Conference
Needham sees orthopedics market slowing; favors Enovis, Paragon 28
Needham says it expects growth in the orthopedic device market to slow later this year, but sees Enovis (ENOV) and Paragon 28 (FNA) as being able to beat the trend. Read more here.
Medtech Firm Enovis Sets Strong 2024 Targets As Q4 Earnings Beat Expectations, Analyst Says Growth Intact
Enovis reports Q4 results with net sales surging 11% YoY, reaching $455 million. The growth is attributed to strong performance in P&R and above-market expansion in Recon, coupled with recent acquisitions impact.
Enovis Corporation Non-GAAP EPS of $0.79 beats by $0.05, revenue of $455.02M beats by $9.63M (NYSE:ENOV)
Enovis Corporation beats earnings and revenue expectations in Q4 2023, and announces strong financial projections for 2024 including the Lima acquisition.
Enovis Announces Fourth Quarter and Full Year 2023 Results
Enovis Announces Fourth Quarter and Full Year 2023 Results
Continued strong momentum with fourth-quarter sales growth of 11%, organic growth of 8% Reported fourth-quarter net income from continuing operations of...
Stephens starts Enovis at overweight, cites "compelling" growth story (NYSE:ENOV)
Stephens has started Enovis (ENOV) with an overweight rating, citing its "compelling" growth story. Stephens commented that Enovis has become a “significant pla
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
Enovis™ to Highlight Latest Technologies Across the Orthopedic Care Continuum at 2024 AAOS Annual Meeting
WILMINGTON, DE, Feb. 12, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology company, will showcase its...
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
Enovis to Present at the Canaccord Genuity Musculoskeletal Conference on Monday, February 12, 2024
Wilmington, DE, Feb. 07, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, today...
Enovis Showcases New Foot & Ankle Offerings at the ACFAS Annual Meeting
New solutions in Percutaneous and Open Bunion procedures, External Fixation, and STAR® Ankle will be featured as part of the company’s growing evidence-based, innovative portfolio.
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
Enovis to Host Fourth Quarter and Full Year 2023 Conference Call on February 22nd
Wilmington, DE, Jan. 26, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV), an innovation-driven, medical technology growth company, announced...
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
The newest innovation in unloader braces is comfortable, easy to use and effective.
Enovis Introduces the DonJoy ROAM™ OA Knee Brace
The newest innovation in unloader braces is comfortable, easy to use and effective....
Enovis finalise l’acquisition de LimaCorporate S.p.A.
WILMINGTON, Delaware, 03 janv. 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE : ENOV, « Enovis » ou la « société ») une entreprise en pleine...
Enovis schließt Übernahme von LimaCorporate S.p.A. ab
WILMINGTON, Delaware, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Die Enovis™ Corporation (NYSE: ENOV, „Enovis“ oder das „Unternehmen“), ein...
의료기술 기업Enovis, LimaCorporate 인수 완료
델라웨어주 윌밍턴, Jan. 04, 2024 (GLOBE NEWSWIRE) -- 혁신 기반의 의료 기술 성장 기업인 Enovis™ Corporation (뉴욕증권거래소: ENOV, 이하 “Enovis” 또는 “회사”)가 혁신적인 임플란트 솔루션을 통해 신체 동작 기능의...
Enovis Selesaikan Pemerolehan LimaCorporate S.p.A
WILMINGTON, Del., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” atau “Syarikat”) sebuah syarikat pertumbuhan teknologi...
Enovis Conclui Aquisição da LimaCorporate S.p.A
WILMINGTON, Del., Jan. 03, 2024 (GLOBE NEWSWIRE) -- A Enovis™ Corporation (NYSE: ENOV, “Enovis” ou a “Empresa”) uma empresa de crescimento de tecnologia...
Enovis cierra adquisición de LimaCorporate S.p.A
WILMINGTON, Delaware, Jan. 03, 2024 (GLOBE NEWSWIRE) -- Enovis™ Corporation (NYSE: ENOV, “Enovis” o la “Empresa”), una Empresa de crecimiento de...